World Mitochondria Society awarded Minovia during Targeting Mitochondria 2019
The Scientific Committee of Targeting Mitochondria 2019 is honored to discern the Innovation Award to Minovia for their clinical study on the Mitochondria Augmentation Therapy.
The study performed by Minovia and presented during Targeting Mitochondria 2019 "Mitochondria augmentation therapy (MAT): mitochondrial enrichment of hematopoietic stem cells in patients with mitochondrial disease", suggest that MAT can diminish disease progression in patients with mtDNA disorders.
For media information
Media center: World Mitochondria Society
Contact: www.targeting-mitochondria.com
